Immunosuppression abrogates resistance of young rabbits to Rabbit Haemorrhagic Disease (RHD)

Veterinary Research

Volumn 45, Issue 1, 2014, Pages

  Marques, Raquel M ^a   Teixeira, Luzia ^a   Águas, Artur P ^a   Ribeiro, Joana C ^a   Costa E Silva, António ^a   Ferreira, Paula G ^a  

^a UNIVERSITY OF PORTO   (Portugal)

Author keywords

[No Author keywords available]

Indexed keywords

ANTIINFLAMMATORY AGENT; DRUG DERIVATIVE; METHYLPREDNISOLONE; METHYLPREDNISOLONE ACETATE;

AGE; ANIMAL; ANIMAL DISEASE; ARTICLE; CALICIVIRUS INFECTION; DISEASE RESISTANCE; DRUG EFFECT; ENZYME LINKED IMMUNOSORBENT ASSAY; IMMUNOLOGY; IMMUNOSUPPRESSIVE TREATMENT; INNATE IMMUNITY; LAGOVIRUS; PHYSIOLOGY; RABBIT; VIROLOGY;

AGE FACTORS; ANIMALS; ANTI-INFLAMMATORY AGENTS; CALICIVIRIDAE INFECTIONS; DISEASE RESISTANCE; ENZYME-LINKED IMMUNOSORBENT ASSAY; HEMORRHAGIC DISEASE VIRUS, RABBIT; IMMUNITY, INNATE; IMMUNOSUPPRESSION; METHYLPREDNISOLONE; RABBITS;

EID: 84893159341     PISSN: 09284249     EISSN: 12979716     Source Type: Journal    
DOI: 10.1186/1297-9716-45-14     Document Type: Article

References (30)

1. Identification and characterization of the virus causing rabbit hemorrhagic disease. Ohlinger VF, Haas B, Meyers G, Weiland F, Thiel HJ, J Virol 1990 64 3331 3336 2352325
2. Purification and characterization of a calicivirus as the causative agent of a lethal hemorrhagic disease in rabbits. Parra F, Prieto M, J Virol 1990 64 4013 4015 2164609 (Pubitemid 20227231)
3. Rabbit haemorrhagic disease (RHD) and rabbit haemorrhagic disease virus (RHDV): a review. Abrantes J, van der Loo W, Le Pendu J, Esteves PJ, Vet Res 2012 43 12 10.1186/1297-9716-43-12 22325049
4. Hepatic lesions in young rabbits experimentally infected with rabbit haemorrhagic disease virus. Mikami D, Park JH, Kimura T, Ochiai K, Itakura C, Res Vet Sci 1999 66 237 242 10.1053/rvsc.1998.0266 10333465 (Pubitemid 129539313)
5. Transient decrease in blood heterophils and sustained liver damage caused by calicivirus infection of young rabbits that are naturally resistant to rabbit haemorrhagic disease. Ferreira PG, Costa-e-Silva A, Monteiro E, Oliveira MJ, Aguas AP, Res Vet Sci 2004 76 83 94 10.1016/j.rvsc.2003.08.003 14659734 (Pubitemid 38035536)
6. Leukocyte-hepatocyte interaction in calicivirus infection: differences between rabbits that are resistant or susceptible to rabbit haemorrhagic disease (RHD). Ferreira PG, Costa-e-Silva A, Oliveira MJ, Monteiro E, Aguas AP, Vet Immunol Immunopathol 2005 103 217 221 10.1016/j.vetimm.2004.09.028 15621308 (Pubitemid 40038208)
7. Binding of rabbit hemorrhagic disease virus to antigens of the ABH histo-blood group family. Ruvoën-Clouet N, Ganière JP, André-Fontaine G, Blanchard D, Le Pendu J, J Virol 2000 74 11950 11954 10.1128/JVI.74.24.11950-11954.2000 11090195 (Pubitemid 32222345)
8. Histo-blood group antigens act as attachment factors of rabbit hemorrhagic disease virus infection in a virus strain-dependent manner. Nyström K, Le Gall-Reculé G, Grassi P, Abrantes J, Ruvoën-Clouet N, Le Moullac-Vaidye B, Lopes AM, Esteves PJ, Strive T, Marchandeau S, Dell A, Haslam SM, Le Pendu J, PLoS Pathog 2011 7 1002188 10.1371/journal.ppat.1002188 21901093
9. Rabbit haemorrhagic disease: an investigation of some properties of the virus and evaluation of an inactivated vaccine. Smid B, Valicek L, Rodak L, Stepanek J, Jurak E, Vet Microbiol 1991 26 77 85 10.1016/0378-1135(91)90043-F 1850893
10. Experimental infections of rabbits with rabbit haemorrhagic disease virus monitored by polymerase chain reaction. Shien JH, Shieh HK, Lee LH, Res Vet Sci 2000 68 255 259 10.1053/rvsc.1999.0372 10877972 (Pubitemid 30495319)
11. Liver disease in young rabbits infected by calicivirus through nasal and oral routes. Ferreira PG, Costa-e-Silva A, Aguas AP, Res Vet Sci 2006 81 362 365 10.1016/j.rvsc.2006.02.001 16624359 (Pubitemid 44313495)
12. Immunohistochemical localisation of rabbit haemorrhagic disease virus VP-60 antigen in early infection of young and adult rabbits. Prieto JM, Fernandez F, Alvarez V, Espi A, Garcia Marin JF, Alvarez M, Martin JM, Parra F, Res Vet Sci 2000 68 181 187 10.1053/rvsc.1999.0357 10756137
13. Vaccination against and immune response to viral haemorrhagic disease of rabbits: a review of research in the People's Republic of China. Huang HB, Rev Sci Tech 1991 10 481 498 1760587
14. Severe leukopenia and liver biochemistry changes in adult rabbits after calicivirus infection. Ferreira PG, Costa-e-Silva A, Oliveira MJ, Monteiro E, Cunha EM, Aguas AP, Res Vet Sci 2006 80 218 225 10.1016/j.rvsc.2005.05.007 16002110 (Pubitemid 43033459)
15. Early acute depletion of lymphocytes in calicivirus-infected adult rabbits. Marques RM, Costa ESA, Aguas AP, Teixeira L, Ferreira PG, Vet Res Commun 2010 34 659 668 10.1007/s11259-010-9437-7 20697811
16. Early inflammatory response of young rabbits attending natural resistance to calicivirus (RHDV) infection. Marques RM, Costa-E-Silva A, Aguas AP, Teixeira L, Ferreira PG, Vet Immunol Immunopathol 2012 150 181 188 10.1016/j.vetimm.2012.09.038 23092749
17. A simple and rapid method for isolation of caliciviruses from liver of infected rabbits. Teixeira L, Marques RM, Aguas AP, Ferreira PG, Res Vet Sci 2011 91 164 166 10.1016/j.rvsc.2010.08.004 20825960
18. Immunosuppression with high-doses of cyclophosphamide reduces the severity of myocarditis but increases the mortality in murine Coxsackievirus-B3 myocarditis. Kishimoto C, Thorp KA, Abelmann WH, Circulation 1990 82 982 989 10.1161/01.CIR.82.3.982 2168299 (Pubitemid 20316750)
19. Characterization of a single dose methylprednisolone acetate immune suppression model using Cryptosporidium muris and Cryptosporidium parvum. Miller TA, Schaefer FW 3rd, Vet Parasitol 2006 141 66 83 10.1016/j.vetpar.2006.04.016 16757117 (Pubitemid 44345020)
20. Methylprednisolone acetate immune suppression produces differing effects on Cryptosporidium muris oocyst production depending on when administered. Miller TA, Schaefer FW 3rd, Vet Parasitol 2007 149 77 84 10.1016/j.vetpar.2007. 07.005 17719178 (Pubitemid 47391132)
21. Rabbit hemorrhagic disease: a review with special reference to its epizootiology. Mitro S, Krauss H, Eur J Epidemiol 1993 9 70 78 10.1007/BF00463093 8386104 (Pubitemid 23071733)
22. Natural killer T cell activation inhibits hepatitis B virus replication in vivo. Kakimi K, Guidotti LG, Koezuka Y, Chisari FV, J Exp Med 2000 192 921 930 10.1084/jem.192.7.921 11015434
23. CD8(+) T cells mediate viral clearance and disease pathogenesis during acute hepatitis B virus infection. Thimme R, Wieland S, Steiger C, Ghrayeb J, Reimann KA, Purcell RH, Chisari FV, J Virol 2003 77 68 76 10.1128/JVI.77.1.68- 76.2003 12477811 (Pubitemid 36004947)
24. Regulation of innate CD8+ T-cell activation mediated by cytokines. Freeman BE, Hammarlund E, Raue HP, Slifka MK, Proc Natl Acad Sci U S A 2012 109 9971 9976 10.1073/pnas.1203543109 22665806
25. Macrophages in hepatitis B and hepatitis C virus infections. Heydtmann M, J Virol 2009 83 2796 2802 10.1128/JVI.00996-08 18842723
26. Pathogenic molecular mechanisms in an animal model of fulminant hepatic failure: rabbit hemorrhagic viral disease. Sanchez-Campos S, Alvarez M, Culebras JM, Gonzalez-Gallego J, Tunon MJ, J Lab Clin Med 2004 144 215 222 10.1016/j.lab.2004.07.006 15514590 (Pubitemid 39423409)
27. Signaling pathways involved in liver injury and regeneration in rabbit hemorrhagic disease, an animal model of virally-induced fulminant hepatic failure. Garcia-Lastra R, San-Miguel B, Crespo I, Jorquera F, Alvarez M, Gonzalez-Gallego J, Tunon MJ, Vet Res 2010 41 2 10.1051/vetres/2009050 19726019
28. Induction of tumor necrosis factor alpha production by human hepatocytes in chronic viral hepatitis. González-Amaro R, García-Monzón C, García-Buey L, Moreno-Otero R, Alonso JL, Yagüe E, Pivel JP, López-Cabrera M, Fernández-Ruiz E, Sánchez-Madrid F, J Exp Med 1994 179 841 848 10.1084/jem.179.3.841 7509363 (Pubitemid 24065641)
29. The hepatitis B virus X protein up-regulates tumor necrosis factor alpha gene expression in hepatocytes. Lara-Pezzi E, Majano PL, Gomez-Gonzalo M, Garciia-Monzon C, Moreno-Otero R, Levrero M, Lopez-Cabrera M, Hepatology 1998 28 1013 1021 10.1002/hep.510280416 9755238 (Pubitemid 28450262)
30. Inflammatory responses in Ebola virus-infected patients. Baize S, Leroy EM, Georges AJ, Georges-Courbot MC, Capron M, Bedjabaga I, Lansoud-Soukate J, Mavoungou E, Clin Exp immunol 2002 128 163 168 10.1046/j.1365-2249.2002.01800.x 11982604 (Pubitemid 34451194)